Susquehanna International Group
GSK icon

Susquehanna International Group’s GSK GSK Stock Holding History

Susquehanna International Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.9M Sell
669,400
-102,500
-13% -$5.55M ﹤0.01% 1535
2025
Q4 		$37.9M Buy
771,900
+77,600
+11% +$3.62M ﹤0.01% 1606
2025
Q3 		$30M Buy
694,300
+271,800
+64% +$10.6M ﹤0.01% 1797
2025
Q2 		$16.2M Sell
422,500
-52,600
-11% -$2.01M ﹤0.01% 2241
2025
Q1 		$18.4M Sell
475,100
-274,000
-37% -$10M ﹤0.01% 1820
2024
Q4 		$25.3M Buy
749,100
+254,400
+51% +$9.16M ﹤0.01% 1671
2024
Q3 		$20.2M Sell
494,700
-122,100
-20% -$5M ﹤0.01% 1821
2024
Q2 		$23.7M Buy
616,800
+190,100
+45% +$8M ﹤0.01% 1555
2024
Q1 		$18.3M Sell
426,700
-575,200
-57% -$23.7M ﹤0.01% 1881
2023
Q4 		$37.1M Sell
1,001,900
-1,093,000
-52% -$39.2M 0.01% 1254
2023
Q3 		$75.9M Buy
2,094,900
+893,800
+74% +$31.7M 0.02% 759
2023
Q2 		$42.8M Sell
1,201,100
-365,500
-23% -$13.1M 0.01% 1102
2023
Q1 		$55.7M Sell
1,566,600
-468,900
-23% -$16.4M 0.01% 887
2022
Q4 		$71.5M Buy
2,035,500
+77,100
+4% +$2.57M 0.02% 708
2022
Q3 		$57.6M Buy
1,958,400
+112,880
+6% +$4.28M 0.01% 738
2022
Q2 		$100M Sell
1,845,520
-305,680
-14% -$16.9M 0.02% 515
2022
Q1 		$117M Sell
2,151,200
-552,400
-20% -$30M 0.02% 592
2021
Q4 		$149M Buy
2,703,600
+1,007,040
+59% +$52.4M 0.02% 562
2021
Q3 		$81M Buy
1,696,560
+224,320
+15% +$11.3M 0.01% 886
2021
Q2 		$73.3M Buy
1,472,240
+593,520
+68% +$28.5M 0.01% 944
2021
Q1 		$39.2M Buy
878,720
+186,160
+27% +$8.45M 0.01% 1285
2020
Q4 		$31.9M Sell
692,560
-58,400
-8% -$2.68M 0.01% 1324
2020
Q3 		$35.3M Buy
750,960
+78,240
+12% +$3.92M 0.01% 1070
2020
Q2 		$34.3M Sell
672,720
-176,160
-21% -$9.04M 0.01% 1031
2020
Q1 		$40.2M Sell
848,880
-414,800
-33% -$22.1M 0.01% 756
2019
Q4 		$74.2M Buy
1,263,680
+16,720
+1% +$930K 0.02% 613
2019
Q3 		$66.5M Buy
1,246,960
+302,560
+32% +$15.6M 0.02% 597
2019
Q2 		$47.2M Sell
944,400
-282,560
-23% -$14.2M 0.02% 719
2019
Q1 		$64.1M Buy
1,226,960
+88,800
+8% +$4.44M 0.03% 502
2018
Q4 		$54.4M Buy
1,138,160
+97,440
+9% +$4.8M 0.02% 573
2018
Q3 		$52.3M Sell
1,040,720
-19,520
-2% -$992K 0.02% 686
2018
Q2 		$53.4M Buy
1,060,240
+321,280
+43% +$16.2M 0.02% 658
2018
Q1 		$36.1M Sell
738,960
-147,120
-17% -$6.85M 0.01% 820
2017
Q4 		$39.3M Sell
886,080
-262,160
-23% -$12.1M 0.01% 814
2017
Q3 		$58.3M Sell
1,148,240
-58,560
-5% -$2.97M 0.02% 574
2017
Q2 		$65M Sell
1,206,800
-119,120
-9% -$6.35M 0.03% 496
2017
Q1 		$69.9M Sell
1,325,920
-158,720
-11% -$8.05M 0.04% 442
2016
Q4 		$71.5M Sell
1,484,640
-209,360
-12% -$10.3M 0.04% 424
2016
Q3 		$91.3M Buy
1,694,000
+89,440
+6% +$4.9M 0.04% 345
2016
Q2 		$86.9M Buy
1,604,560
+36,080
+2% +$1.9M 0.05% 340
2016
Q1 		$79.5M Buy
1,568,480
+337,680
+27% +$16.8M 0.04% 379
2015
Q4 		$62.1M Sell
1,230,800
-170,160
-12% -$8.67M 0.03% 519
2015
Q3 		$67.3M Buy
1,400,960
+62,880
+5% +$3.27M 0.03% 496
2015
Q2 		$69.7M Buy
1,338,080
+414,880
+45% +$23.4M 0.03% 525
2015
Q1 		$53.3M Buy
923,200
+94,400
+11% +$5.41M 0.02% 596
2014
Q4 		$44.3M Sell
828,800
-84,560
-9% -$4.73M 0.02% 791
2014
Q3 		$52.5M Buy
913,360
+328,160
+56% +$20.1M 0.02% 721
2014
Q2 		$39.1M Buy
585,200
+51,280
+10% +$3.47M 0.02% 859
2014
Q1 		$35.7M Buy
533,920
+259,760
+95% +$17.6M 0.02% 831
2013
Q4 		$18.3M Sell
274,160
-205,200
-43% -$13.3M 0.01% 1436
2013
Q3 		$30.1M Buy
479,360
+142,960
+42% +$9.2M 0.02% 909
2013
Q2 		$21M Buy
+336,400
New +$21.4M 0.01% 1084

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group's GSK Position: Q1 2026 in Review

Susquehanna International Group increased its GSK (GSK) stake by 568% in Q1 2026, buying an estimated $2.65M and bringing the position to 57,448 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #5165.

Susquehanna International Group first reported a position in GSK in Q2 2013 and has held it in 47 quarters since. The position peaked at $54.8M in Q4 2014. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Susquehanna International Group held 57,448 shares of GSK worth $3.17M as of Q1 2026.
  • Susquehanna International Group bought 48,853 GSK shares in Q1 2026, an estimated $2.65M.
  • GSK made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5165 holding.
  • Susquehanna International Group first reported a position in GSK in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's GSK position peaked at $54.8M in Q4 2014.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.